Yes, anemia can be genetic. Several forms of anemia are caused by inherited gene mutations that affect how your body produces hemoglobin, builds red blood cell membranes, or maintains the enzymes red blood cells need to survive. Some of these conditions are common: roughly 1 in 66 people in the United States carries a trait for an inherited hemoglobin disorder. Others are rare but serious, affecting the bone marrow itself.
How Genetic Anemia Differs From Nutritional Anemia
Most people associate anemia with iron deficiency, and that’s the most common type worldwide. But iron deficiency anemia is caused by diet, blood loss, or absorption problems, not by your DNA. Genetic anemias, by contrast, are baked into your genes from birth. You can eat a perfect diet and still be anemic if you’ve inherited a condition that disrupts red blood cell production or lifespan.
This distinction matters practically. If you’re treated with iron supplements and your hemoglobin levels don’t return to normal, a genetic form of anemia like thalassemia minor is a strong possibility. In fact, one classic clinical clue is that people with thalassemia minor have normal iron stores in their bone marrow, while people with iron deficiency do not. The two conditions can look similar on a routine blood count, so the difference often only becomes clear after iron therapy fails or after more specialized testing.
Sickle Cell Disease
Sickle cell disease is the most well-known genetic anemia. It’s caused by a single point mutation in the gene that codes for the beta chain of hemoglobin, located on chromosome 11. That one small change produces an abnormal form of hemoglobin called hemoglobin S, which causes red blood cells to warp into a rigid, crescent shape under low-oxygen conditions. These sickle-shaped cells get stuck in small blood vessels, leading to episodes of severe pain, organ damage, and chronic anemia because the misshapen cells break down much faster than normal ones.
Sickle cell disease follows an autosomal recessive inheritance pattern, meaning you need to inherit the faulty gene from both parents to develop the disease. If you inherit it from only one parent, you’re a carrier (sometimes called having sickle cell trait) and typically don’t have symptoms. Roughly 300,000 infants are born with sickle cell disease each year worldwide, with the highest rates in sub-Saharan Africa, India, and the Middle East. In Africa, the under-five mortality rate among children with the disease ranges from 5% to 16%.
Thalassemia
Thalassemia is actually a group of genetic anemias, split into two main categories based on which part of the hemoglobin molecule is affected. Alpha thalassemia involves the alpha chain, and beta thalassemia involves the beta chain. The inheritance patterns and severity differ between the two.
Four genes control alpha chain production. You inherit two from each parent. The severity of alpha thalassemia depends directly on how many of those four genes are missing. Losing one gene usually causes no symptoms at all. Losing two causes mild anemia. Losing three causes a more serious condition called hemoglobin H disease. Losing all four is typically fatal before or shortly after birth.
Beta thalassemia works differently. Only two genes control beta chain production, one from each parent. Instead of whole gene deletions, small mutations within the gene reduce how much beta chain your body makes. Inheriting one mutated copy (beta thalassemia minor) usually causes mild anemia that many people live with without ever knowing the cause. Inheriting two mutated copies can cause beta thalassemia major, a severe condition that often requires regular blood transfusions starting in early childhood.
Red Blood Cell Membrane Disorders
Your red blood cells normally have a smooth, flexible, disc-like shape that lets them squeeze through the tiniest blood vessels. That shape depends on a scaffolding of proteins just beneath the cell’s outer membrane. When genes coding for these structural proteins are mutated, the cells lose their flexibility and take on abnormal shapes.
The most common of these conditions is hereditary spherocytosis, where red blood cells become small and round (sphere-shaped) instead of disc-shaped. The key proteins involved, spectrin and ankyrin among others, act like the internal skeleton of the cell. When they’re deficient or abnormal, the membrane loses stability, and the misshapen cells are flagged and destroyed by the spleen faster than normal, causing chronic anemia. Related conditions include hereditary elliptocytosis, where cells become oval-shaped, and several rarer membrane disorders.
G6PD Deficiency
G6PD deficiency is one of the most common enzyme disorders in the world, affecting hundreds of millions of people. The G6PD enzyme protects red blood cells from oxidative damage. Without enough of it, red blood cells are vulnerable to breaking apart when exposed to certain triggers, including specific medications, infections, and even some foods like fava beans.
What makes G6PD deficiency unusual among genetic anemias is its inheritance pattern. The gene sits on the X chromosome, which means it follows X-linked inheritance. Boys have only one X chromosome, so a single copy of the faulty gene from their mother is enough to cause the condition. Girls have two X chromosomes, so they need to inherit the faulty gene from both parents to be fully affected. Girls who inherit just one copy are carriers and may have partial enzyme activity, but they typically don’t experience significant symptoms. This is why G6PD deficiency is far more common in males.
Unlike sickle cell disease or thalassemia, G6PD deficiency doesn’t cause constant anemia. Instead, red blood cells break down in episodes triggered by external stressors. Between episodes, blood counts are often normal. When a hemolytic episode does occur, red blood cells can be destroyed so rapidly that they circulate for far less than their normal 90-day lifespan.
Fanconi Anemia and Bone Marrow Failure
Most genetic anemias affect red blood cells directly, either their hemoglobin, membrane, or enzymes. Fanconi anemia is different. It’s the most common inherited cause of bone marrow failure, meaning the factory that produces all blood cells gradually shuts down. This leads to low counts across red blood cells, white blood cells, and platelets.
More than 23 genes have been linked to Fanconi anemia, all of them involved in DNA repair. When these genes are mutated, cells accumulate chromosomal damage they can’t fix. The blood-forming stem cells in the bone marrow are especially sensitive to this damage and are selectively destroyed over time. Fanconi anemia is usually inherited in an autosomal recessive pattern, though about 2% of cases are X-linked.
Because Fanconi anemia affects all blood cell lines rather than just red blood cells, it’s a fundamentally different condition from the hemolytic anemias described above. It also carries an increased risk of certain cancers, particularly leukemia, making early diagnosis important.
Carrier Screening and Testing
If you’re planning a pregnancy or already pregnant, carrier screening can reveal whether you carry genes for inherited anemias. The American College of Obstetricians and Gynecologists now recommends offering universal hemoglobinopathy testing to anyone planning pregnancy or at their first prenatal visit, regardless of racial or ethnic background. Previous guidelines used race-based screening, but self-identified ethnicity turns out to be a poor proxy for genetic ancestry.
Testing typically involves hemoglobin electrophoresis, which separates different types of hemoglobin in a blood sample to identify abnormal variants like hemoglobin S. Molecular genetic testing, including expanded carrier panels, can also detect mutations associated with sickle cell disease, thalassemia, and other inherited conditions. For people already diagnosed or suspected of having a genetic anemia, newer techniques like next-generation sequencing can pinpoint the specific mutations responsible.
When both parents carry a trait for the same condition, each pregnancy carries a 25% chance of producing a child with the full disease. Knowing your carrier status before or early in pregnancy opens up options including preimplantation genetic testing during IVF and prenatal diagnosis through amniocentesis or chorionic villus sampling.
Why Genetic Anemia Can Go Undiagnosed
Mild forms of genetic anemia, particularly thalassemia minor and single-gene-deletion alpha thalassemia, often fly under the radar for years. They produce slightly low hemoglobin and small red blood cells on a blood count, a pattern that looks almost identical to iron deficiency. Many people are prescribed iron supplements repeatedly without improvement before anyone considers a genetic cause.
If you’ve been told you have mild anemia that doesn’t respond to iron, or if you have a family history of anemia that seems to run through generations, genetic testing can provide a definitive answer. The distinction isn’t just academic. Taking iron supplements you don’t need won’t help a genetic anemia, and in some cases, unnecessary iron supplementation can lead to iron overload over time.